Overview

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
ZA-300 is meant to determine the safety profile of Androxal (enclomiphene citrate) in men with secondary hypogonadism.
Phase:
Phase 3
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Zuclomiphene